|Revenue||₹9,500 crore (US$1.2 billion) (2018)|
|₹590 crore (US$80 million) (2018)|
|Total assets||₹4,345 crore (US$590 million) (2019)|
Number of employees
Patanjali Ayurved, is an Indian multinational consumer packaged goods company, based in Haridwar, India, that was started by Ramdev and Balkrishna in 2006. Its manufacturing units and headquarters are located in the industrial area of Haridwar, Uttarakhand while the registered office is located at Delhi. The company manufactures mineral and herbal products.
According to a company official, sales in early March 2016 were ₹45 billion (US$630 million) with monthly sales of ₹5 billion (US$70 million)–₹5.5 billion (US$77 million). Acharya Balkrishna remains the CEO of Patanjali Ayurved with 96% shareholding and supervising its day-to-day activities, while Ramdev remains the face of the company and makes most of the business decisions.
The company has been accused of misleading advertisements about its products and flimsy testing before being launched to market. Some products like amla juice, and ayurvedic medicines  have been banned from sales due to poor quality. Patanjali has also been surrounded in controversies regarding working conditions where Ramdev and Acharya Balkrishna are treated at gurus whose feet must be touched each time they enter an area. Workers are paid a salary of just 6000 INR per month while working in 12-hour shifts for 6 days a week. They are also discouraged to ask for a raise as working at factory is considered "seva" (service) to the cause.
In June 2020, Patanjali Ayurved announced a drug named Coronil for COVID-19 treatment, Ramdev claimed in June that Coronil had cured Covid-19 patients. The Indian government has allowed Patanjali Ayurved to market Coronil as an immunity booster but not a cure. The Government of Maharashtra has banned the sale of Coronil in the state. Law suits were filed in Bihar and Rajasthan against Ramdev, Balkrishna, and others, accusing them of cheating and selling fake medicines. The Madras High Court has fined the company ₹1,000,000 (US$14,000) for its false claims on the drug. Patanjali has withdrawn the claim of Coronil being a cure for Covid-19. The UK drug regulator has threatened action if the unauthorized products were sold in the UK market.
Ramdev established the Patanjali Ayurved Limited in 2006 along with Balkrishna, with the objective of establishing "science" of Ayurveda in accordance and coordination with the latest technology and ancient wisdom.
According to CLSA and HSBC in 2016, Patanjali was the fastest growing FMCG company in India. It is valued at ₹3,000 crore (equivalent to ₹35 billion or US$490 million in 2019) and some predict revenues of ₹5,000 crore (US$700 million) for the fiscal 2015–16. Patanjali declared its annual turnover of the year 2016–17 to be estimated ₹10,216 crore (US$1.4 billion). According to a report by India Infoline (IIFL), at least 13 listed companies would be affected by Patanjali's success including Colgate, Dabur, ITC and Godrej Consumer.
Patanjali Food and Herbal Park at Haridwar is the main production facility operated by Patanjali Ayurved. The company has a production capacity of ₹35,000 crore (equivalent to ₹380 billion or US$5.3 billion in 2019) and is in the process of expanding to a capacity of ₹60,000 crore (equivalent to ₹690 billion or US$9.7 billion in 2019) through its new production units at several places, including Noida, Nagpur, and Indore.
In 2016, the Patanjali Food and Herbal Park was given a full-time security cover of 35 armed Central Industrial Security Force (CISF) commandos. The park will be the eighth private institute in India to be guarded by CISF paramilitary forces. Ramdev himself is a "Z" category protectee of central paramilitary forces.
Ramdev had approximately 100 cases filed against him by the Uttarakhand Government in under various offences. Out of which 81 cases against the Patanjali Yog Peeth and its sister concerns in Haridwar were registered for violation of the Zamindari Abolition and Land Reforms (ZALR) Act and the Indian Stamps Act.
Infertility cure for boy
One of the product manufactured by Ramdev's Divya pharmacy and sold by Patanjali Pharmacy chain was named "Divya Putrajeevak Seed", a medicine that can guarantee the birth of boy. It was described in catalogue as a natural herb for treatment of infertility. Doctors pointed out the misleading name of the drug as the word "Putrajeevak" in Hindi means "baby life giver." Some stores of the chain were selling the drug claiming that it will ensure the birth of a boy. This lead to a rise in sale of the drug among people seeking a boy. The claim of boy is not mentioned on packet of the drug.
In July 2015, the issue was also raised in the Indian Parliament by members of Opposition party who accused "Ramdev of peddling a product which promised delivery of male children." However, the Ministry of AYUSH which oversees the sale of alternative medicines, had defended the product, saying the medicine was named after a herb.
In 2016, the Uttarakhand health department said that the drug by Patanjali Ayurveda was in violation of the Indian law, Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994. In 2018, Maharashtra government ordered a probe on the drug over charges that it violated laws. Congress leaders in the state demanded a ban on the drug.
Ban Ganga river pollution
In January 2018, villages in Haridwar district complained that one of the Patanjali's factory named Padarth was polluting Ban Ganga rivulet and a few other rain-fed water bodies in the locality by releasing effluents. According to the locals, the chemicals released by the factory had caused death of several animals in the area over the years. The villagers had complained but the local government took no action on the factory due to the influence of Ramdev. Residents of 40 villages had threatened agitations due to the inaction of the local bodies in taking action against pollution. Uttarakhand Environment Conservation and Pollution Control Board directed a clean up of the Begum nullah flowing through the area. In past the board had served a notice to Padartha over the release of untreated industrial effluents into local water bodies. Patanjali General Manager denied the allegations and claimed that it followed the protocols.
Suspension of Amla juice
The Ministry of Defence's canteen stores department (CSD) had suspended the sale of Patanjali Ayurved's amla juice after receiving an adverse state-laboratory test report on the product.
The move came after the product was tested at the central food lab that found it to be unfit for consumption. After which, the CSD asked all its depots to make debit notes for their existing stock so that the product can be returned.
Notice by FSSAI
Patanjali launched instant noodles on 15 November 2015. Food Safety and Standards Authority of India slapped a notice on the company as neither Patanjali nor Aayush, which are the two brand names under which Patanjali got licenses, have got any approval for manufacturing instant noodles.
Fake COVID-19 treatment
In June 2020, Patanjali Ayurved announced the launch of a COVID-19 treatment kit called Coronil, claiming that it showed 100% favorable results in clinical trials on coronavirus patients. Ramdev claimed in June that Coronil had cured Covid-19 patients. There was no clinical data to prove that these new drugs were effective or even safe, and this prompted a backlash on social media, with people questioning the role of the Ministry of AYUSH. Within hours of the launch, the Ministry of AYUSH issued a statement, denying having given clearance for the launch of the new drugs and asking the company to stop selling or advertising the product until the trial results were examined by medical authorities. An officer from the Ayurved department of the Government of Uttarakhand stated that the approval application for the new drugs had not mentioned COVID-19.
The Government of Maharashtra banned Coronil in the state in June 2020, with home minister Anil Deshmukh threatening the company with legal action if they did not respect the ban. Following the launch two FIRs were registered in Bihar and Rajasthan against Ramdev, Balkrishna, and others, accusing them of cheating and selling fake medicines. Patanjali responded to the accusations claiming that they did not violate any procedure leading up to the launch. Patanjali has withdrawn the claim of Coronil being a cure for Covid-19.
The Madras High Court has also barred Patanjali Ayurved from using the trademark ‘Coronil’. The court’s order came while hearing a suit filed by a Chennai-based firm which claimed that ‘Coronil’ is a trademark owned by it since 1993. While making absolute an interim injunction passed earlier against Patanjali, Justice C.V. Karthikeyan also imposed a fine of Rs 10 lakh on the company. The judge in its ruling also observed that Patanjali has been “chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus, when actually their ‘Coronil Tablet’ is not a cure”.
False claims regarding government and WHO approvals
In February 2021, a number of news outlets, including Indian Express, Times of India, The Hindu, and Livemint carried reports that Patanjali Ayurved claimed that Coronil had received approval from the Ministry of AYUSH as well as certification from the World Health Organization. These reports indicated that Ramdev had, at a press conference attended by Union Health Minister Harsh Vardhan and transport minister Nitin Gadkari, released studies showing that Coronil was effective against COVID-19. The claim was first reported by channel News Nation, which did an exclusive interview with Ramdev, in which he accused medical doctors of engaging in 'allopathic terrorism' with reference to doubts about the effectivess of Coronil. The claim was endorsed by Bharatiya Janata Party spokesperson, Sanju Verma, who described it as a "....a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt." Verma, speaking for the BJP, also described the approvals granted to Coronil as a "slap in the face" to the BJP's political opposition.
In response to these claims, the World Health Organisation on 22 February clarified that it had not "...reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.” Several news and fact-checking outlets, including The Wire, Alt News, and Economic Times ran fact-checking articles debunking the claims made by Ramdev and Patanjali, and demonstrating that Coronil had merely received a license for export, and had not received any approval regarding its effectiveness as a treatment against Covid-19. Following this, the CEO of Patanjali Ayurveda, Acharya Balkrishna, admitted on Twitter that the approval received for Coronil had not come from either the WHO or the Ministry of AYUSH, as they had earlier claimed, but had been granted by the Drugs Controller General of India only for the purpose of exports, and not as a certification of effectiveness.
Patanjali Ayurved produces products in the categories of personal care and food. The company manufactures more than 2,500 products including 45 types of cosmetic products and 30 types of food products. According to Patanjali, all the products manufactured by Patanjali are made from Ayurveda and natural components. Patanjali has also launched beauty and baby products. Patanjali Ayurvedic manufacturing division has over 300 medicines for curing a range of ailments and body conditions, from common cold to chronic diseases like paralysis.
In 2016, Patanjali has announced to enter the textile manufacturing centre. The company is reported to manufacture not only traditional clothes such as Kurta Payjama but also popular western clothes such as jeans.
On 5 November 2016, Patanjali announced that it will set up a new manufacturing plant Patanjali Herbal and Mega Food Park in Balipara, Assam by investing ₹1,200 crore (US$170 million) with the manufacturing capacity of 10 lakh tonnes of goods per year. The new plant will be the largest facility of Patanjali in India and will be operational by March 2017. Patanjali already has around 50 manufacturing units across India.
Sales and distribution
Patanjali Ayurved sells through nearly 4,700 retail outlets as of May 2016. Patanjali also sells its products online and is planning to open outlets at railway stations and airports. Patanjali Ayurveda has tied up with Pittie Group and Kishore Biyani's Future Group on 9 October 2015. As per the tie-up with Future Group, all the consumer products of Patanjali will be available for the direct sale in Future Group outlets. Patanjali Ayurveda products are also available in modern trade stores including Reliance retail, Hyper city and Star Bazaar apart from online channels. Patanjali Ayurved, co-founded by yoga guru Ramdev, is targeting ₹10,000-crore revenue in 2016–17, after sales grew 150% in the previous financial year to ₹5,000 crore.
In December 2019, Patanjali has acquired bankrupt Ruchi Soya Industries at a valuation of ₹4350 crore. At present Ruchi Soya is a mid cap company listed on NSE and BSE in India. It's a major soyabean product player in India.
- "Patanjali CEO Acharya Balkrishna Among India's Richest: ChaMagazine". NDTV. NDTV. 18 September 2016. Retrieved 10 January 2017.
- "Patanjali to launch 'Swadeshi' jeans soon, exploring global markets with FMCG". Firstpost. 12 September 2016. Retrieved 4 December 2016.
- "Employment for more than 2 lac : Food & Herbal Park, Patanjali Ayurved". IBTL. 22 September 2012.
- Bahree, Megha (26 October 2016). "India's Baba Ramdev Billionaire Is Not Baba Ramdev". Forbes. Retrieved 16 February 2017.
- Aradhak, Purusharth. "430 acres allotted to Patanjali". The Hindu. Retrieved 26 February 2017.
- "Patanjali on track to hit $1 billion sales in FY17", The Economic Times, 16 March 2016
- "Baba Ramdev's Patanjali starts to take a toll on some FMCG firms", The Economic Times, 29 February 2016
- "Ramdev's Patanjali products fail quality test, RTI inquiry finds". Hindustan Times. 29 May 2017. Retrieved 7 October 2020.
- Dangwal, Sandhya (24 April 2017). "CSD withdraws Baba Ramdev's popular product after lab declares it unfit for consumption". India News, Breaking News, Entertainment News | India.com. Retrieved 7 October 2020.
- "Military Canteens Ban sales of Patanjali Amla Juice". Saying Truth. 24 April 2017. Retrieved 7 October 2020.
- "Nepal drug administration reject six Patanjali products after tests, contain pathogenic bacteria - India News, Firstpost". Firstpost. 22 June 2017. Retrieved 7 October 2020.
- "Covid-19: Fake 'immunity booster' found on sale in London shops". BBC News. 19 December 2020. Retrieved 21 December 2020.
- Afreen, Jasra (29 June 2020). "Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim". Hindusthan Times. Retrieved 29 June 2020.
- "FIR against 5 over Covid-19 'medicine' claim: Ramdev, Patanjali MD booked for 'cheating'". Indian Express. 29 June 2020. Retrieved 29 June 2020.
- "Patanjali Ayurved FAQ's". Patanjali Ayurverd. Archived from the original on 7 February 2016. Retrieved 22 January 2016.
- "Baba Ramdev's Business Empire Soars, With His Own Rising Profile". HuffPost India.
-  "The Patanjali effect" Business-Standard
- "Forbes profile: Acharya Balkrishna". Forbes. Retrieved 16 March 2018.
- "Are PEs bending over backwards to invest in Patanjali?". The Hindu. 11 January 2016.
- "Patanjali is disrupting India's consumer space". IIFL. 6 February 2016.
- "HSBC Global Rsearch cuts target prices of Britannia Dabur and Nestle between 6% and 16%, says Patanjali". Economic Times. 5 February 2016.
- Arnab Dutta (5 May 2017). "Ramdev's Patanjali shakes up FMCG order; next up 'nutritious restaurants'". Business Standard. Archived from the original on 15 July 2017. Retrieved 15 July 2017.
- "Patanjali sales growth grinds to a halt in FY18", Livemint, 18 May 2018
- "Patanjali and its grand plans: Ramdev expects Rs 20,000 cr revenue in FY18", Business Standard, 4 May 2017
- "Patanjali reports Rs 8,339 crore revenue in FY 19; food items account for 62% of total sales", Business Today, 19 November 2019
- "Baba Ramdev's Patanjali Group compels FMCG firms Hindustan Unilever and Dabur to expand portfolio". IBT times. 26 January 2016.
- http://www.india.com/news/india/patanjali-ayurved-doubles-its-profit-in-one-year-set-to-catch-up-with-rivals-1051546/ Patanjali Ayurved doubles its profit in one year; set to catch up with rivals
- "Inside Baba Ramdev's Patanjali empire".
- "Ramdev to open herbal factory in Nepal". Web Dunia. 18 April 2015.
- "Patanjali herbal park in Nepal". Insight TV News Network. 28 February 2015.
- Yadav, Yatish (9 March 2016). "CISF Team to Guard Ramdev's Food Park". NEW DELHI: Indian Express.
- Sharma, Varun (8 March 2016). "Ramdev's Food Park Gets Round-The-Clock Protection From Paramilitary CISF". NDTV.
- "Ramdev's food park gets full-time CISF cover". The Tribune India. 9 March 2016.
- "Swadeshi ringtone: Patanjali aims to stretch its outreach". The Pioneer. 30 August 2017.
- Prashant, Shishir (20 March 2017). "With BJP in power, focus is now on cases against Baba Ramdev". Business Standard India. Retrieved 21 December 2020.
- "81 cases filed against Ramdev". The Hindu. 20 November 2013. Retrieved 21 December 2020.
- "In Name of Ramdev's Infertility Cure, the Promise of a Boy Child?". NDTV.com. Retrieved 21 December 2020.
- "Ramdev's 'Putrajeevak beej' is named after herb: AYUSH minister". Business Standard India. 26 May 2015. Retrieved 21 December 2020.
- Azad, Shivani (2 February 2018). "U'khand says Ramdev's fertility pill 'Putrajeevak Beej' violates PNDT Act | Dehradun News - Times of India". The Times of India. TNN. Retrieved 21 December 2020.
- Naik, Yogesh (21 July 2018). "Govt to probe sale of controversial Patanjali product". Mumbai Mirror. Retrieved 21 December 2020.
- "Villagers say Patanjali unit polluting water bodies in Haridwar". Hindustan Times. 23 January 2018. Retrieved 21 December 2020.
- "Defence canteens remove Ramdev's Patanjali amla juice after adverse lab report". Retrieved 18 May 2020.
- "Ramdev's Patanjali launches noodles". The Hindu. 16 November 2015.
- "FSSAI sends notice to Baba Ramdev's company". ibnlive.com.
- "Trouble mounts for Ramdev's Atta Noodles, FSSAI issues notice to Patanjali Ayurved". Navbharat Times.
- "No Approval for Patanjali Instant Noodles, Says Food Safety Regulator". NDTV. 18 November 2015.
- "'No licence for noodles': FSSAI slaps showcause on Patanjali". The Indian Express. 21 November 2015.
- "Patanjali's Atta Noodles in trouble: Baba Ramdev breaks silence, drags Modi govt into controversy". oneindia.com. 19 November 2015.
- "Patanjali Atta noodles gets notice". livehindustan.com.
- Kumar, Ravi Prakash (23 June 2020). "Coronavirus treatment: Ramdev's Patanjali launches Coronil kit for ₹545". Livemint. Retrieved 24 June 2020.
- "Baba Ramdev's Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know". The Financial Express. 23 June 2020. Retrieved 24 June 2020.
- Narayanan, Kavya (28 June 2020). "AYUSH Ministry is endangering people, jeopardising Ayurveda with lax response to Patanjali's Coronil and COVID-19, warn experts". Firstpost. Retrieved 29 June 2020.
- "Govt asks Patanjali to stop ads of Covid drug". Hindustan Times. 23 June 2020. Retrieved 24 June 2020.
- "Ramdev's Patanjali Asked By Government To Explain COVID Drug Claim". NDTV.com. Retrieved 24 June 2020.
- "Ayush Ministry Stops Patanjali From Selling, Advertising Purported Covid Medicine". BloombergQuint. Retrieved 24 June 2020.
- "Patanjali's Coronil approval application did not mention coronavirus: Licence officer". India Today. 24 June 2020. Retrieved 29 June 2020.
- Shrivastava, Sonu (26 June 2020). "Maharashtra bans Patanjali's COVID-19 medicine 'Coronil'." Asian Age. Retrieved 29 June 2020.
- Sahay, Abhinav (24 June 2020). "'All parameters met': Patanjali claims Coronil clinical trial details furnished to Centre". Hindusthan Times. Retrieved 29 June 2020.
- M, Apoorva; hani (6 August 2020). "Patanjali can't use Coronil trademark, says Madras High Court, fines it Rs 10 lakh". ThePrint. Retrieved 18 February 2021.
- Lobo, Shalini (6 August 2020). "Patanjali chased profits by exploiting public fear: Madras HC imposes Rs 10 lakh fine on firm". India Today. Retrieved 18 February 2021.
- "Madras HC: Patanjali cannot use 'Coronil' branding, must pay Rs 10 lakh fine for exploiting fear". cnbctv18.com. Retrieved 18 February 2021.
- "Patanjali exploited public fear says Madras HC, imposes Rs 10 lakh fine". The News Minute. 6 August 2020. Retrieved 18 February 2021.
- "Patanjali Ayurved fined Rs 10 lakh by Madras HC for chasing profits by claiming COVID-19 'cure'". The New Indian Express. Retrieved 18 February 2021.
- "Patanjali Fined Rs 10 Lakh by Madras HC for Chasing Profits amid Covid-19 Fear, Using Coronil Trademark". News18. 6 August 2020. Retrieved 18 February 2021.
- "Coronil has received AYUSH certification as per WHO norms: Patanjali". The Indian Express. 20 February 2021. Archived from the original on 19 February 2021. Retrieved 21 February 2021.
- "Coronil has received Ayush Ministry certification as per WHO scheme: Patanjali". mint. 19 February 2021. Archived from the original on 19 February 2021. Retrieved 21 February 2021.
- PTI; 2021 (19 February 2021). "Patanjali coronil: Coronil gets Ayush ministry certification as per WHO scheme: Patanjali". The Times of India. Archived from the original on 19 February 2021. Retrieved 21 February 2021.CS1 maint: numeric names: authors list (link)
- "Coronil gets Ayush Ministry certification as 'supporting measure' for COVID-19 treatment". The Hindu. PTI. 19 February 2021. ISSN 0971-751X. Retrieved 21 February 2021.CS1 maint: others (link)
- Chaudhuri, Pooja (21 February 2021). "Fact Check: Patanjali's Coronil Neither WHO Certified nor Approved". The Wire Science. Retrieved 21 February 2021.
- "Tweet: @Sanju_Verma". Twitter. 19 February 2021.
- Awasthi, Prashasti. "WHO clarifies it hasn't reviewed or certified Coronil for Covid-19 treatment". @businessline. Retrieved 21 February 2021.
- Bhushan, Ratna. "Patanjali's Coronil not WHO certified or approved; no traditional medicine certified by WHO for Covid cure". The Economic Times. Retrieved 21 February 2021.
- "Patanjali's Coronil is neither WHO certified nor approved, media outlets run false news". Alt News. 20 February 2021. Retrieved 21 February 2021.
- Upadhyay, Kavita. "Patanjali Ayurved fined Rs. 11 lakh". The Hindu. Retrieved 13 July 2017.
- "Divya Putrajeevak Seed natural herb for treatment of infertility". NDTV. 29 January 2015.
- "Ramdev's herbal factory now in America". The Echo of Nepal. 17 April 2015. Archived from the original on 5 May 2015.
- "Ramdev's ayurvedic products to foray into open market". Business Today. 2 March 2012.
- "Cosmetics after yoga". ABP News. 13 January 2015. Archived from the original on 18 January 2015. Retrieved 20 October 2015.
- "Here's Why Baba Ramdev Is Making Corporate India Uncomfortable". Indiatimes. 13 January 2015.
- "We plan to open Patanjali outlets at Railway stations, airports: Ramdev". 21 May 2015.
- "Ramdev turns his Ayurved enterprise into an FMCG empire". 28 June 2015.
- "Patanjali to launch baby-care products". Business Standard. 17 November 2015.
- "Ramdev's Patanjali biggest domestic buyer of red sanders". The Times of India. 17 April 2015.
- "From soaps to cornflakes: Did you know Baba Ramdev is an FMCG tycoon". Firstpost. 13 January 2015.
- "Balkrishna launches elixir for children". WebIndia. 23 May 2015.
- "Baba Ramdev wants to sell Patanjali products through 30 lakh shops, online by 2017 - The Economic Times". The Economic Times. Retrieved 7 November 2016.
- "Baba Ramdev expands empire beyond yoga to FMCG". The Economic Times. 13 January 2015.
- "Ramdev's Patanjali Ayurved enters big retail with Future Group tie-up". India Today.
- "Ramdev products available in Big bazaar". Nayi Duniya. 9 October 2015.
- "Future group and Patanjali tie-up". Patrika. 9 October 2015.
- "Future Group partners Patanjali Ayurveda". The Hindu. 9 October 2015.
- "Patanjali products to be sold in Khadi bhandars". Amar Ujala. 18 December 2014.
- "Baba Ramdev's Patanjali Ayurveda to make, sell DRDO food products". ABP Live. 25 August 2015.
- "Baba Ramdev's Patanjali Ayurveda To Sell DRDO Food Products". HuffPost India. 24 August 2015.
-  "Patanjali Ayurved to invest Rs 1,150 crores, eyes doubling revenue" The Hindu
- Dutta, Arnab (27 April 2016). "Baba Ramdev's Patanjali aims to double its revenue to Rs 10,000 cr in 2016-17". Retrieved 16 March 2018 – via Business Standard.
- "Patanjali Ayurved Ltd Distributorship and Dealership process online". CDN Times. 21 November 2016.
- "Patanjali Completes Acquisition Of Ruchi Soya". BloombergQuint. Retrieved 2 May 2020.